“…The 68 RCTs included a total of 4195 participants (ranging from 14 to 313 participants per RCT). The trials were conducted in high to upper-middle income economies: Australia (3 RCTs) [ 22 , 72 , 90 ], Brazil (7 RCTs) [ 23 , 25 , 26 , 47 , 48 , 74 , 77 ], Canada (2 RCTs) [ 64 , 67 ], China (8 RCTs) [ 53 , 54 , 68 – 71 , 83 , 88 ], France (1 RCT) [ 78 ], Germany (3 RCTs) [ 28 , 49 , 50 ], Italy (1 RCT) [ 45 ], Japan (1 RCT) [ 24 ], Malaysia (1 RCT) [ 37 ], Netherlands (1 RCT) [ 29 ], South Korea (4 RCTs) [ 65 , 66 , 76 , 86 ], Thailand (1 RCT) [ 59 ], Turkey (1 RCT) [ 31 ], United Kingdom (1 RCT) [ 32 ], and the United States (2 RCTs) [ 33 , 46 ]; and low to lower-middle income economies: Egypt (2 RCTs) [ 37 , 52 ], India (5 RCTs) [ 21 , 51 , 55 , 79 , 87 ], Iran (18 RCTs) [ 27 , 29 , 40 , 42 – 44 , 56 – 58 , 62 , 63 , 72 , 75 , 81 , 81 , 83 , 84 , 89 ], Nigeria (2 RCTs) [ 59 , 91 ], and Pakistan (4 RCTs) [ 39 ...…”